{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:06:29Z","timestamp":1740107189351,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s00381-023-06218-2","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T10:02:03Z","timestamp":1699610523000},"page":"831-837","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of tuberous sclerosis complex manifestations in children with mTOR inhibitors"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2328-8612","authenticated-orcid":false,"given":"\u015eule","family":"Ye\u015fil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3474-5070","authenticated-orcid":false,"given":"Bur\u00e7ak","family":"Kurucu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6875-5766","authenticated-orcid":false,"given":"Melda Berber","family":"Hamamc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5777-6147","authenticated-orcid":false,"given":"\u015e\u00fckriye","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8569-3971","authenticated-orcid":false,"given":"G\u00fcrses","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"6218_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","volume":"372","author":"P -Curatolo","year":"2008","unstructured":"-Curatolo P, Bombardieri R, Jozwiak S (2008) Tuberous sclerosis. Lancet 372:657\u2013668","journal-title":"Lancet"},{"key":"6218_CR2","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","volume":"75","author":"-European Chromosome 16 Tuberous Sclerosis Consortium","year":"1993","unstructured":"-European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305\u20131315","journal-title":"Cell"},{"key":"6218_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M -van Slegtenhorst","year":"1997","unstructured":"-van Slegtenhorst M, de Hoogt R, Hermans C et al (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805\u2013808","journal-title":"Science"},{"key":"6218_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jaad.2007.05.004","volume":"57","author":"RA -Schwartz","year":"2007","unstructured":"-Schwartz RA, Fern\u00e1ndez G, Kotulska K et al (2007) Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol 57:189\u2013202","journal-title":"J Am Acad Dermatol"},{"key":"6218_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","volume":"49","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Northrup H (2013) Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49:255\u2013265","journal-title":"Pediatr Neurol"},{"key":"6218_CR6","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.002","volume":"49","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Northrup H (2013) Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 49:243\u2013254","journal-title":"Pediatr Neurol"},{"key":"6218_CR7","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3906\/sag-2002-133","volume":"50","author":"SP -Uysal","year":"2020","unstructured":"-Uysal SP, \u015eahin M (2020) Tuberous sclerosis: a review of the past, present, and future. Turk J Med Sci 50:1665\u20131676","journal-title":"Turk J Med Sci"},{"key":"6218_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2133.2008.08677.x","volume":"159","author":"GF -Hofbauer","year":"2008","unstructured":"-Hofbauer GF, Marcollo-Pini A, Corsenca A et al (2008) The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis. Br J Dermatol 159:473\u2013475","journal-title":"Br J Dermatol"},{"key":"6218_CR9","doi-asserted-by":"crossref","unstructured":"-Merkel S, Mogilevskaja N, Mengel M et al (2006) Side effects of sirolimus. Transplant Proc. 38:714-5","DOI":"10.1016\/j.transproceed.2006.01.044"},{"key":"6218_CR10","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/j.1365-2133.2011.10471.x","volume":"165","author":"M -Wataya-Kaneda","year":"2011","unstructured":"-Wataya-Kaneda M, Tanaka M, Nakamura A et al (2011) A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different Disease severity. Br J Dermatol 165:912\u2013916","journal-title":"Br J Dermatol"},{"issue":"1","key":"6218_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0378-6323.190844","volume":"83","author":"LS -Cinar","year":"2017","unstructured":"-Cinar LS, Kartal D, Bayram AK et al (2017) Topical sirolimus for the treatment of angiofibromas in tuberous sclerosis. Indian J Dermatology Venereol Leprology 83(1):27\u201332","journal-title":"Indian J Dermatology Venereol Leprology"},{"key":"6218_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/ndt\/gfu013","volume":"29","author":"JC -Kingswood","year":"2014","unstructured":"-Kingswood JC, Jozwiak S, Belousova ED et al (2014) The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, phase 3 trial EXIST-1. Nephrol Dial Transplant 29:1203\u20131210","journal-title":"Nephrol Dial Transplant"},{"key":"6218_CR13","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","volume":"381","author":"JJ -Bissler","year":"2013","unstructured":"-Bissler JJ, Kingswood JC, Radzikowska E et al (2013) Everolimus for Angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 381:817\u2013824","journal-title":"Lancet"},{"key":"6218_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/ndt\/gfv249","volume":"31","author":"JJ -Bissler","year":"2016","unstructured":"-Bissler JJ, Kingswood JC, Radzikowska E et al (2016) Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial. Nephrol Dial Transplant 31:111\u2013119","journal-title":"Nephrol Dial Transplant"},{"key":"6218_CR15","doi-asserted-by":"crossref","unstructured":"-Bissler JJ, Radzikowska E, Zonnenberg BA et al (2016) Everolimus for renal angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: final long-term results from EXIST-2. Munich: Presented at the 31st European Association of Urology (EAU) Annual Congress","DOI":"10.1016\/S1569-9056(16)60759-5"},{"key":"6218_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.urology.2015.12.009","volume":"89","author":"A -Kapoor","year":"2016","unstructured":"-Kapoor A, Girard L, Lattouf JB et al (2016) Evolving strategies in the treatment of Tuberous Sclerosis Complexassociated Angiomyolipomas (TSC-AML). Urology 89:19\u201326","journal-title":"Urology"},{"key":"6218_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13023-018-0781-y","volume":"13","author":"Y -Cai","year":"2018","unstructured":"-Cai Y, Guo H, Wang W et al (2018) Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial. Orphanet J Rare Dis 13:43","journal-title":"Orphanet J Rare Dis"},{"key":"6218_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa063564","volume":"358","author":"JJ -Bissler","year":"2008","unstructured":"-Bissler JJ, McCormack FX, Young LR et al (2008) Sirolimus for Angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 358:140\u2013151","journal-title":"N Engl J Med"},{"key":"6218_CR19","doi-asserted-by":"publisher","first-page":"744050","DOI":"10.3389\/fmed.2021.744050","volume":"8","author":"C -Luo","year":"2021","unstructured":"-Luo C, Ye WR, Zu XB et al (2021) Low-dose Everolimus maintenance therapy for renal Angiomyolipoma Associated with Tuberous Sclerosis Complex. Front Med 8:744050","journal-title":"Front Med"},{"issue":"6","key":"6218_CR20","doi-asserted-by":"publisher","first-page":"e001493","DOI":"10.1161\/JAHA.114.001493","volume":"3","author":"RB -Hinton","year":"2014","unstructured":"-Hinton RB, Prakash A, Romp RL et al (2014) International Tuberous Sclerosis Consensus Group. Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group. J Am Heart Assoc 3(6):e001493","journal-title":"J Am Heart Assoc"},{"key":"6218_CR21","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1542\/peds.2010-0192","volume":"127","author":"BA -Staley","year":"2011","unstructured":"-Staley BA, Vail EA, Thiele EA (2011) Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs. Pediatrics 127:e117\u2013e125","journal-title":"Pediatrics"},{"key":"6218_CR22","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/08830738040190090401","volume":"19","author":"FJ -DiMario Jr","year":"2004","unstructured":"-DiMario FJ Jr (2004) Brain abnormalities in tuberous sclerosis complex. J Child Neurol 19:650\u2013657","journal-title":"J Child Neurol"},{"key":"6218_CR23","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1177\/08830738040190090801","volume":"19","author":"EA -Thiele","year":"2004","unstructured":"-Thiele EA (2004) Managing Epilepsy in tuberous sclerosis complex. J Child Neurol 19:680\u2013686","journal-title":"J Child Neurol"},{"key":"6218_CR24","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","volume":"51","author":"CJ -Chu-Shore","year":"2010","unstructured":"-Chu-Shore CJ, Major P, Camposano S et al (2010) The natural history of Epilepsy in tuberous sclerosis complex. Epilepsia 51:1236\u20131241","journal-title":"Epilepsia"},{"key":"6218_CR25","first-page":"1","volume":"51","author":"DN -Franz","year":"2017","unstructured":"-Franz DN, Capal JK (2017) mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disorders. Orphanet J Rare Dis 51:1\u20139","journal-title":"Orphanet J Rare Dis"},{"key":"6218_CR26","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","volume":"388","author":"JA -French","year":"2016","unstructured":"-French JA, Lawson JA, Yapici Z et al (2016) Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, doubleblind, placebo-controlled study. Lancet 388:2153\u20132163","journal-title":"Lancet"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-023-06218-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-023-06218-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-023-06218-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T11:12:58Z","timestamp":1708686778000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-023-06218-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["6218"],"URL":"https:\/\/doi.org\/10.1007\/s00381-023-06218-2","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"type":"print","value":"0256-7040"},{"type":"electronic","value":"1433-0350"}],"subject":[],"published":{"date-parts":[[2023,11,10]]},"assertion":[{"value":"16 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}